Dose-related pharmacologic effects of high-dose ara-C and its self-potentiation.
D000375:Aging; D000818:Animals; D001086:Arabinofuranosyluracil / Q000378:metabolism; D001692:Biological Transport; D001853:Bone Marrow / Q000378:metabolism; D002460:Cell Line; D002462:Cell Membrane / Q000378:metabolism; D002986:Clinical Trials as Topic; D003561:Cytarabine / Q000008:administration & dosage* / Q000378:metabolism / Q000627:therapeutic use; D004247:DNA / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D004351:Drug Resistance; D006207:Half-Life; D006801:Humans; D007399:Interphase; D007938:Leukemia / Q000188:drug therapy* / Q000378:metabolism; D007940:Leukemia L5178 / Q000188:drug therapy; D013997:Time Factors
D003561:Cytarabine; D001086:Arabinofuranosyluracil; D004247:DNA